Cizzle Biotechnology commercial & royalty agreement represents a very significant deal for the company (LON:CIZ) 9 February 2022
Quadrise Fuels International test results will support and hopefully accelerate the plans on the larger scale trials (LON:QFI) 9 February 2022
Ilika plc: First Commercial Revenues Signal Pivotal Shift in Solid-State Battery Journey (Video) 26 January 2026
Ilika Plc: Solid-State Breakthroughs Put Stereax and Goliath in the Spotlight (Video) 23 January 2026
City of London Investment Group results beat Zeus Capital’s revenue forecast by 4.1% 15 September 2020
Surface Transforms “well positioned to deliver for the medium-term” says Zeus Capital 15 September 2020
CentralNic Group “Codewise acquisition could raise monetisation market share to 37%” says Zeus Capital 14 September 2020
OnTheMarket “is playing a major role in the increase in residential property market activity” says Zeus Capital 11 September 2020
DWF Group “has a strong platform well suited to the changing legal services market” says Zeus Capital 9 September 2020
ACG Metals positioned for strong cash generation and long-term value as copper production ramps up, highlights DIVI fund manager 6 February 2026
Primary Health Properties surplus cash fuels generous dividend, Gervais Williams impressed 4 February 2026
Arbuthnot Banking Group ‘remarkably low valuation given its prospects’ says DIVI Fund Manager 4 February 2026
Workspace Group PLC (WKP.L) Investor Outlook: What the 14.29% Potential Upside Means for You 6 February 2026
Zigup Plc (ZIG.L) Stock Analysis: Industrial Rental Services Giant with a 30% Upside Potential 6 February 2026
WH Smith PLC (SMWH.L) Investor Outlook: Navigating Potential Upside Amidst Market Challenges 6 February 2026
XPS Pensions Group PLC (XPS.L): Analyst Consensus Points to 29% Upside Potential for UK-Based Pension Specialist 6 February 2026
WORLDWIDE HEALTHCARE TRUST PLC (WWH.L) Stock Analysis: A Look at Recent Price Movements Amidst Strong Buy Ratings 6 February 2026
Cizzle Biotechnology commercial & royalty agreement represents a very significant deal for the company (LON:CIZ) 9 February 2022
Quadrise Fuels International test results will support and hopefully accelerate the plans on the larger scale trials (LON:QFI) 9 February 2022
Ilika plc: First Commercial Revenues Signal Pivotal Shift in Solid-State Battery Journey (Video) 26 January 2026
Ilika Plc: Solid-State Breakthroughs Put Stereax and Goliath in the Spotlight (Video) 23 January 2026
City of London Investment Group results beat Zeus Capital’s revenue forecast by 4.1% 15 September 2020
Surface Transforms “well positioned to deliver for the medium-term” says Zeus Capital 15 September 2020
CentralNic Group “Codewise acquisition could raise monetisation market share to 37%” says Zeus Capital 14 September 2020
OnTheMarket “is playing a major role in the increase in residential property market activity” says Zeus Capital 11 September 2020
DWF Group “has a strong platform well suited to the changing legal services market” says Zeus Capital 9 September 2020
ACG Metals positioned for strong cash generation and long-term value as copper production ramps up, highlights DIVI fund manager 6 February 2026
Primary Health Properties surplus cash fuels generous dividend, Gervais Williams impressed 4 February 2026
Arbuthnot Banking Group ‘remarkably low valuation given its prospects’ says DIVI Fund Manager 4 February 2026
Workspace Group PLC (WKP.L) Investor Outlook: What the 14.29% Potential Upside Means for You 6 February 2026
Zigup Plc (ZIG.L) Stock Analysis: Industrial Rental Services Giant with a 30% Upside Potential 6 February 2026
WH Smith PLC (SMWH.L) Investor Outlook: Navigating Potential Upside Amidst Market Challenges 6 February 2026
XPS Pensions Group PLC (XPS.L): Analyst Consensus Points to 29% Upside Potential for UK-Based Pension Specialist 6 February 2026
WORLDWIDE HEALTHCARE TRUST PLC (WWH.L) Stock Analysis: A Look at Recent Price Movements Amidst Strong Buy Ratings 6 February 2026
MoonLake Immunotherapeutics (MLTX) Stock Analysis: Exploring a 30% Upside Potential in the Biotech Sector 6 January 2026
Celldex Therapeutics (CLDX) Stock Analysis: Biotechnology Innovator with Over 100% Upside Potential 6 January 2026
Travere Therapeutics, Inc. (TVTX) Stock Analysis: Exploring a 10.77% Upside Potential in the Biotech Sector 6 January 2026
Azenta, Inc. (AZTA) Stock Analysis: Exploring a 19.81% Potential Upside in the Healthcare Sector 6 January 2026
Edgewise Therapeutics, Inc. (EWTX) Stock Analysis: Exploring a 61.93% Upside Potential in Biotech 6 January 2026
Ardent Health, Inc. (ARDT) Stock Analysis: Unveiling a Potential 52.87% Upside for Investors 6 January 2026
Pediatrix Medical Group, Inc. (MD) Stock Analysis: Assessing the 3.5% Potential Upside and Market Position 6 January 2026
Recursion Pharmaceuticals, Inc. (RXRX) Investor Outlook: Uncovering a 60% Upside Potential in Biotech Innovation 6 January 2026
Pacira BioSciences, Inc. (PCRX): Analyst Ratings Suggest an 18% Upside Potential for Investors 6 January 2026
Galapagos NV (GLPG) Stock Analysis: Navigating Biotech Volatility with Strategic Insights 6 January 2026
Schrodinger, Inc. (SDGR) Stock Analysis: Unveiling a 47% Upside Potential Amidst Robust Revenue Growth 6 January 2026
Novavax, Inc. (NVAX) Stock Analysis: Exploring a 76% Potential Upside in the Biotechnology Sector 6 January 2026
Dyne Therapeutics, Inc. (DYN) Stock Analysis: A Closer Look at its 113% Upside Potential 6 January 2026
Beam Therapeutics Inc. (BEAM) Investor Outlook: Navigating Biotech with a 71% Upside Potential 6 January 2026
CG Oncology, Inc. (CGON) Investor Outlook: Exploring the 76.61% Potential Upside in Cutting-Edge Bladder Cancer Therapies 6 January 2026
PetroNeft Resources looking to 2022 with an incredible degree of optimism (Interview) 23 December 2021
Aferian strong pipeline, good position and high visibility give real confidence for 2022 (Interview) 17 December 2021
Immotion Group revenue to be very significantly ahead of that reported in H1 2021 (Interview) 16 December 2021
Scottish Mortgage Investment Trust Plc appoints Christopher Samuel as an independent NED 8 November 2024
Cizzle Biotechnology commercial & royalty agreement represents a very significant deal for the company (LON:CIZ) 9 February 2022
Quadrise Fuels International test results will support and hopefully accelerate the plans on the larger scale trials (LON:QFI) 9 February 2022
City of London Investment Group results beat Zeus Capital’s revenue forecast by 4.1% 15 September 2020
Surface Transforms “well positioned to deliver for the medium-term” says Zeus Capital 15 September 2020
CentralNic Group “Codewise acquisition could raise monetisation market share to 37%” says Zeus Capital 14 September 2020
OnTheMarket “is playing a major role in the increase in residential property market activity” says Zeus Capital 11 September 2020
DWF Group “has a strong platform well suited to the changing legal services market” says Zeus Capital 9 September 2020
ACG Metals positioned for strong cash generation and long-term value as copper production ramps up, highlights DIVI fund manager 6 February 2026
Primary Health Properties surplus cash fuels generous dividend, Gervais Williams impressed 4 February 2026
Arbuthnot Banking Group ‘remarkably low valuation given its prospects’ says DIVI Fund Manager 4 February 2026
Ilika plc: First Commercial Revenues Signal Pivotal Shift in Solid-State Battery Journey (Video) 26 January 2026
Ilika Plc: Solid-State Breakthroughs Put Stereax and Goliath in the Spotlight (Video) 23 January 2026
Workspace Group PLC (WKP.L) Investor Outlook: What the 14.29% Potential Upside Means for You 6 February 2026
Zigup Plc (ZIG.L) Stock Analysis: Industrial Rental Services Giant with a 30% Upside Potential 6 February 2026
WH Smith PLC (SMWH.L) Investor Outlook: Navigating Potential Upside Amidst Market Challenges 6 February 2026
XPS Pensions Group PLC (XPS.L): Analyst Consensus Points to 29% Upside Potential for UK-Based Pension Specialist 6 February 2026
WORLDWIDE HEALTHCARE TRUST PLC (WWH.L) Stock Analysis: A Look at Recent Price Movements Amidst Strong Buy Ratings 6 February 2026
